All Deals
July 8, 2026 - Deals
Omni Ventures Closes $33 Million Fund To Back Pre-Seed Startups Digitizing Manufacturing Technology
Omni Ventures, a San Jose-based venture capital firm founded by former Apple engineers Simon Lancaster and Sabrina Paseman, has closed an oversubscribed $33 million debut fund focused on backing pre-seed startups digitizing manufacturing technology. The firm invests $700,000 to $1 million in companies developing software, AI, robotics, automation, and connected industrial systems designed to unlock factory-floor data and modernize industrial supply chains. Supported by investors from 14 countries and anchored by Allocator One, Omni Ventures has already begun deploying capital, including participation in Mimiq’s $4 million seed round, while offering portfolio companies hands-on industry expertise and customer adoption support.
FOUNDERS: Simon Lancaster & Sabrina Paseman
AMOUNT: $33,000,000
HQ: San Jose, California
#VentureCapital #OmniVentures #SimonLancaster #SabrinaPaseman #TradedVC
More Deals
View All
Mercor In Talks To Raise $20 Billion Following Deeptune Acquisition And Revenue GrowthMercor, an AI training startup, is reportedly in early discussions to raise a new funding round at a $20 billion valuation. The potential valuation would double the company’s $10 billion valuation from October 2025, when it raised a $350 million Series C round. Founder and CEO Brendan Foody recently stated that Mercor’s annualized revenue run rate has surpassed $2 billion, representing 100% growth in just four months. The company also announced the acquisition of Deeptune, an AI agent training firm, with the entire Deeptune team joining Mercor. The strong revenue growth, acquisition activity, and prospective funding round suggest Mercor is continuing to expand despite challenges earlier this year, including a data breach and legal disputes involving contract workers.
FOUNDER: Brendan Foody
AMOUNT: $20,000,000,000
HQ: San Francisco, California
#VentureCapital #Mercor #BrendanFoody #TradedVC
Klinic Secures $24 Million In Seed And Series A Funding From Proofpoint Capital And I2BF Global VenturesKlinic, an AI-enabled specialty care access platform, has raised $24 million in combined seed and Series A funding to expand its provider network, enhance its AI-powered platform, and grow its life sciences partnerships. The round was co-led by Proofpoint Capital and I2BF Global Ventures, with representatives from both firms joining Klinic’s board. Founded and led by CEO Avish Bhama, Klinic helps patients navigate the often complex specialty care journey by using artificial intelligence and workflow automation to streamline provider matching, insurance verification, prior authorizations, patient communications, and pharmacy coordination. The company has already supported more than 150,000 patients and aims to make specialty care access faster, more connected, and more affordable.
FOUNDER: Avish Bhama
INVESTORS: Proofpoint Capital & I2BF Global Ventures
ROUND: Seed & Series A
AMOUNT: $24,000,000
HQ: Dallas, Texas
#VentureCapital #Klinic #AvishBhama #TradedVC